Learn how Bayesian design is reshaping clinical trials with adaptive methods that improve efficiency, reduce costs, and support faster, more patient centric drug development.
Novartis used PBPK modeling for therapeutic regulatory success. They used model simulations to replace clinical studies, predict DDIs, and support asciminib’s approval.
